Market Tracker

10/31 7:05pm ET

Amgen Inc (NASDAQ:AMGN)

162.18
Data as of Oct 31
 +0.60 / +0.37%
Today’s Change
108.20
Today|||52-Week Range
164.65
+42.16%
Year-to-Date

Today’s Trading

Previous close161.58
Today’s open164.56
Day’s range161.42 - 164.65
Volume7,973,043
Average volume (3 months)3,892,304
Market cap$122.9B
Dividend yield1.50%
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+20.29%
Earnings growth (this year)+10.54%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+8.61%
P/E ratio24.8
Price/Sales4.60
Price/Book5.52

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen Idec Inc+0.08+0.02%
GILDGilead Sciences Inc-2.22-1.94%
BAXBaxter International...+0.08+0.11%
GEVASynageva BioPharma C...-4.32-5.40%
Data as of 4:14pm ET, 10/31/2014

Financials

Last reporting dateOctober 27, 2014
EPS forecast (this quarter)$2.11
Annual revenue (last year)$18.7B
Annual profit (last year)$5.1B
Net profit margin27.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts